Form 4: Centene Director Kenneth Burdick Receives Stock Grant

Centene Corporation Director Kenneth A. Burdick acquired 3,992 shares of common stock via a restricted stock unit grant.

Summary

• Director Kenneth A. Burdick was granted 3,992 restricted stock units (RSUs) on May 12, 2026.
• The RSUs are scheduled to vest in full on May 12, 2027, or upon the date of the next annual meeting of stockholders, whichever occurs first.
• Following this transaction, Mr. Burdick's direct beneficial ownership of Centene common stock increased to 277,085.924 shares.
• Mr. Burdick maintains an additional indirect interest in 86,498 shares held by Burdick Family LLC.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation with no material impact on company operations or financial strategy.

Positives

• The director's increased equity stake aligns his interests further with those of shareholders.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The restricted stock units are set to vest in one year, contingent upon continued service or the next annual meeting.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to incentivize long-term board commitment and shareholder alignment within the managed healthcare sector.

Comparison to Industry Standards

• The grant of restricted stock units to non-employee directors is consistent with standard compensation practices for S&P 500 healthcare companies.
• The vesting schedule of one year is typical for annual director equity awards.

Related Party Transactions

• The reporting person is the chief manager of Burdick Family LLC, which holds 86,498 shares of Centene common stock.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Vesting of the 3,992 restricted stock units on May 12, 2027.

Key Dates

Keywords

Centene, CNC, Form 4, Insider Trading, Director Compensation, Equity Grant